+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of levonorgestrel and copper releasing intrauterine contraceptive device on body iron stores and menstrual bleeding patterns: experience on Indian women



Comparison of levonorgestrel and copper releasing intrauterine contraceptive device on body iron stores and menstrual bleeding patterns: experience on Indian women



European Review for Medical and Pharmacological Sciences 16(2): 230-234



The search for an ideal contraceptive device most suited for women of developing countries with anemia poses a challenge. This study was conducted to compare the effects of levonorgestrel releasing (LNG) and copper releasing (Cu T) intrauterine contraceptive devices (IUCD) on body iron stores and menstrual bleeding patterns. Hundred women desiring contraception were divided into two groups of fifty each where either LNG or Cu T 200 IUCD was inserted. Outcome parameters evaluated were change in menstrual bleeding patterns, serum ferritin and hemoglobin level post insertion at three, six and twelve months. Main outcome measures were change in serum ferritin, hemoglobin concentration, menstrual bleeding and spotting days 12 months after insertion. Menstrual bleeding days increased initially at three month for both IUCD's, but by 12 months, mean number of bleeding days reduced from preinsertion 4.96 +/- 1.61 to 3.14 +/- 1.72 days (p < 0.05) in the LNG group while in Cu T number of bleeding days remained higher at 12 months (4.76 +/- 0.96 days) compared to pre-insertion level (4.46 +/- 0.91 days, p = NS). At 12 months, 60% women developed hypomenorrhoea and 20% had amenorrhea in LNG group. Higher (p < 0.05) serum ferritin (24.17 + 5.97 vs. 20.80 + 5.78) and hemoglobin (12.45 + 0.46 vs. 11.95 + 11.042 gm/dl) concentration was noted in the LNG group as compared to Cu T by the end of 1 year. LNG reduced the number of menstrual bleeding days and increased the hemoglobin and serum ferritin levels, thus preventing loss of body iron. This may be especially important for women in developing countries like India where decrease in blood loss may improve iron deficient situations.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 052237131

Download citation: RISBibTeXText

PMID: 22428475


Related references

Body iron stores and patterns of bleeding after insertion of a levo norgestrel releasing or a copper releasing intra uterine contraceptive device. Contraception 26(5): 465-474, 1982

Patterns of bleeding and body iron stores during the use of a levonorgestrel-releasing intracervical device. Contraception 38(3): 333-340, 1988

The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years). Minerva Ginecologica 54(3): 271-278, 2002

Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis. Contraception 86(5): 458-463, 2012

Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Contraception. 54(4): 201-208, 1996

Treatment of Women With an Endometrial Polyp and Heavy Menstrual Bleeding: A Levonorgestrel-Releasing Intrauterine Device or Hysteroscopic Polypectomy?. Journal of Minimally Invasive Gynecology 22(7): 1153-1162, 2016

Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies. Contraception 87(1): 107-112, 2013

Comparison of two cohorts of women who expulsed either a copper-intrauterine device or a levonorgestrel-releasing intrauterine system. Journal of Obstetrics and Gynaecology Research 42(5): 554-559, 2016

Levonorgestrel-Releasing Intrauterine Device Use in Female Adolescents with Heavy Menstrual Bleeding and Bleeding Disorders: Single Institution Review. Journal of Pediatric and Adolescent Gynecology 30(4): 479-483, 2017

Puerperal insertion of a copper-releasing and a levonorgestrel-releasing intrauterine contraceptive device. Contraception 25(6): 561-572, 1982

Menstrual bleeding pattern and iron status in women fitted with copper and non-medicated intrauterine contraceptive devices. East African Medical Journal 71(4): 268-270, 1994

Use of a levonorgestrel-releasing intrauterine device in the treatment of adenomyosis associated heavy menstrual bleeding. Jpma. Journal of the Pakistan Medical Association 63(11): 1349-1352, 2013

Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study. Fertility and Sterility 39(2): 187-192, 1983

Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?. Human Reproduction 12(12): 2671-2675, 1997

Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?. Human Reproduction 12(12): 2671-2675, 1997